Siemens Tissue Preparation Solution offers new use to increase molecular lab efficiency
Nov 14, 2013
The Siemens Tissue Preparation Solution now provides molecular pathology laboratories the ability to extract high quality nucleic acids from fresh frozen (FF) tissues as well as from formalin-fixed, paraffin embedded (FFPE) tissues. This makes it today the only fully automated solution available for standardized isolation of nucleic acids from both FFPE and FF tissue samples obtained from surgeries or biopsies for in vitro diagnosis and research.
Usually, FF tissue samples require separate workflows and specific kits not compatible with FFPE tissues, making the integration of these two processes a challenge for molecular pathology labs. Now, the consolidation of both tissue types on the Siemens Tissue Preparation Solution enables labs to fully automate workflows to further increase productivity and efficiency and enable consistent and reliable delivery of testing results.
FF tissues are typically used for quick diagnosis of patients undergoing surgery, research or tissue collection and storage. FFPE tissue samples are routinely prepared from tissues obtained from surgeries and biopsies. In clinical diagnostics, nucleic acids are extracted from these samples for use in infectious disease and oncology testing.
Before the introduction of this Siemens solution, laboratories were limited to systems that were either manual or only automated for certain steps of the process. “When compared to other manual and semi-automated procedures, the Siemens method really sets a new standard in quality and workflow efficiency for routine molecular pathology laboratories,” comments Manfred Dietel, MD, Director of Institute of Pathology, University Hospital, Charité Berlin.
The Siemens Tissue Preparation Solution includes a Tissue Preparation System¹ and Versant Tissue Preparation Reagents kit.
Contact for journalists:
Siemens Healthcare, Media Relations
Phone: +1 914-524-2844; E-mail: firstname.lastname@example.org
For further information on the Siemens Tissue Preparation Solution, please visit: www.healthcare.siemens.com/molecular-diagnostics/molecular-diagnostics-systems/tissue-prep-system.
Follow us on Twitter at: www.twitter.com/siemenshealth
The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Further details are available from the local Siemens organizations.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2013 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 2.0 billion euros. For further information please visit: www.siemens.com/healthcare.
1The Tissue Preparation System consists of a Hamilton MICROLAB® STARlet IVD instrument and Siemens tissue extraction software protocol.